Author: CBD-Intel
How will open access to federally funded research affect US cannabis science?
Written by CBD-Intel || 14th September 2022 || Blog |
The Biden Administration recently released a memorandum requiring research receiving federal funds to be made available to the public without charge. But what effect will this have on cannabis research? ...
Where the parties stand on cannabis ahead of Italian elections this month
Written by CBD-Intel || 12th September 2022 || Regulatory briefing |
The right-wing coalition parties which look most likely to triumph in Italy’s coming elections take a uniformly hard line on drug policy – which could be bad news for the cannabinoids industry ...
German hemp farm raided on grounds crop exceeds country’s 0.2% THC limit
Written by CBD-Intel || 12th September 2022 || Regulatory briefing |
More than two dozen officers carried out a surprise raid on a farm in Dithmarschen on 30th August as part of “an investigation into the joint illegal trade of large quantities of narcotics”, according to the Itzehoe Police Department...
Calls for changes in Canadian cannabis laws as strikes cause supply issues
Written by CBD-Intel || 9th September 2022 || Regulatory briefing |
Canada’s cannabis industry is calling for changes in the way cannabis products are distributed and sold in some parts of the country after labour disputes in two provinces have led to strikes and forced some stores to close...
President puts forward bill to legalise recreational cannabis in Costa Rica
Written by CBD-Intel || 6th September 2022 || Regulatory briefing |
Costa Rica will look to legalise recreational cannabis with a bill presented to Congress ahead of extraordinary legislative sessions in November, president Rodrigo Chaves announced ...
Minnesota Republicans told they should have been careful what they voted for
Written by CBD-Intel || 5th September 2022 || Regulatory briefing |
Some Minnesota legislators have expressed regret after failing to realise that a law clarifying rules around hemp products would permit the sale of edible products with THC levels similar to those seen in recreational cannabis ...
CBD is no more a drug than honey is, industry expert tells FDA science board
Written by CBD-Intel || 5th September 2022 || Regulatory briefing |
If CBD is to be regulated as a drug, then so should honey. That was one of the views put by industry members to the US Food and Drug Administration (FDA) Science Board public advisory committee ...
Colombia sees explosion in medical cannabis exports since rules changed
Written by CBD-Intel || 2nd September 2022 || Regulatory briefing |
The 1st April change to permit the export of medical cannabis from Colombia has sparked an immediate boom in shipments from the South American country ...
CBD-Intel global alerts database September
Written by CBD-Intel || 2nd September 2022 || Alerts Array , Regulatory alerts roundup |
All the stories from the CBD-Intel weekly global regulatory Live Alerts in one user-friendly database, updated every month. This regulatory tool consolidates all of our global regulatory Live Alerts since they were launched in May 2019, collected in Excel...
African nations press on with medical cannabis, but it’s not all plain sailing
Written by CBD-Intel || 1st September 2022 || Business briefing |
Two southern African countries, Malawi and Zimbabwe, are progressing in the advancement of their nascent medicinal cannabis industries ...
China: CBD and cannabis regulation, September 2022
Written by CBD-Intel || 1st September 2022 || Regulatory reports |
Cannabis and cannabis extracts are controlled substances under national legislation in China. This report provides a detailed overview of national and local regulation of hemp, CBD and cannabis ...
Legal challenge coming after Ghana’s Supreme Court halts hemp licensing
Written by CBD-Intel || 31st August 2022 || Regulatory briefing |
Cannabis activists are set to challenge a ruling by the Supreme Court of Ghana which invalidated a section of the country’s Narcotic Control Commission Act 2020 that would have enabled the licensing of hemp production ...
Colombia’s new president out to end ‘war on drugs’ and legalise recreational use
Written by CBD-Intel || 30th August 2022 || Regulatory briefing |
Colombia’s first leftist president says the “war on drugs” has failed and it is now time to look to formerly prohibited crops such as cannabis to boost the country’s economy and bring some justice to victims ...
State legislatures urge Washington to support moves to legalise cannabis
Written by CBD-Intel || 30th August 2022 || Regulatory briefing |
The Republican-influenced National Conference of State Legislatures (NCSL) has explicitly called on the US federal government to support cannabis legalisation measures ...
High costs result in further delays to Belize’s cannabis referendum
Written by CBD-Intel || 29th August 2022 || Regulatory briefing |
Belize will defer a referendum vote on the legalisation of recreational cannabis brought about by opposition from national church leaders in the country, officials have said in a joint statement issued on 4th August ...
Hong Kong: CBD and cannabis regulation, August 2022
Written by CBD-Intel || 24th August 2022 || Regulatory reports |
This report provides a detailed overview of the regulatory framework in place in Hong Kong for hemp, cannabis and CBD ...Delta-8 regulatory tracker historical updates
Written by CBD-Intel || 23rd August 2022 || Regulatory trackers |
As delta-8 US regulation has changed over the years, so have we updated our US CBD delta-8 tracker maps. The following is a historical compilation of these updates, from June 2022 to present. Click on each date to...CBD US enacted maps historical updates
Written by CBD-Intel || 23rd August 2022 || Regulatory trackers |
As CBD regulation has changed over the years, so have we updated our US regulatory tracker: Enacted regulation of CBD maps. The following is a historical compilation of these updates, from September 2020 to present. Click on each...Global regulatory tracker historical updates
Written by CBD-Intel || 23rd August 2022 || Regulatory trackers |
As global CBD regulation has changed over the years, so have we updated our global CBD regulatory tracker maps. The following is a historical compilation of these updates, from February 2021 to present. Click on each date to...
Medical cannabis advocates in the Philippines find government support
Written by CBD-Intel || 19th August 2022 || Regulatory briefing |
Medical cannabis advocates in the Philippines have found an ally in a young senator, but there is still much to do ...
US FDA gets into local enforcement now ‘rather than play whack-a-mole later’
Written by CBD-Intel || 19th August 2022 || Regulatory briefing |
Recent unusual activity by the US Food and Drug Administration (FDA) could be an attempt to strike a heavy blow now in order to avoid continuing to play whack-a-mole with enforcement as time goes on ...
Views invited as Health Canada moves on prescription-free CBD product sales
Written by CBD-Intel || 18th August 2022 || Regulatory briefing |
Canada has moved a step closer to allowing some health products containing CBD to be sold without a prescription as Health Canada embarks on consultation over regulatory plans ...
Could cannabis help improve outcomes for patients badly afflicted by Covid?
Written by CBD-Intel || 18th August 2022 || Blog , Business briefing |
A study published this month provides further evidence that cannabis could be helpful in treating severe late-stage Covid-19 ...
Pennsylvania banking bill welcomed, but it’s federal legislation they all want
Written by CBD-Intel || 17th August 2022 || Regulatory briefing |
A new state law will help shield financial companies in Pennsylvania from prosecution over transactions with legal cannabis companies. But industry leaders say more protection is needed after a federal bill was halted ...
Taiwan: CBD and cannabis regulation, August 2022
Written by CBD-Intel || 17th August 2022 || Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis in Taiwan, covering all policy areas from cultivation and processing to extracts, finished products and import/export ...
US legislators seek to amend cannabis advertising laws ahead of midterms
Written by CBD-Intel || 15th August 2022 || Regulatory briefing |
Advertising of cannabis products looks set to be a potential battleground as the US legislature heads towards midterm elections later this year ...
Three nations aiming to lead EU states toward joined-up cannabis reforms
Written by CBD-Intel || 9th August 2022 || Regulatory briefing |
Germany, Luxembourg and Malta have taken the first step towards working together on the legalisation and regulation of recreational cannabis, leading a wave of potential reform across the EU ...
Peruvian initiative aims to open up hemp industry for rural ‘artisan’ production
Written by CBD-Intel || 5th August 2022 || Regulatory briefing |
A bill put forward in Peru seeks to establish regulation that would allow for the production and commercialisation of industrial hemp in the South American country ...
Swiss CBD company takes issue with EFSA’s delay of novel food applications
Written by CBD-Intel || 1st August 2022 || Business briefing |
A Swiss CBD company has questioned the approach of European authorities in demanding further data in order to advance novel food applications, describing it as an issue that might signal the end of hemp-extracted cannabinoids as a viable...
Argentina’s hemp industry hoping new legal framework will encompass delta-8
Written by CBD-Intel || 19th July 2022 || Regulatory briefing |
The Argentine hemp industry is hopeful that sales of delta-8 THC hemp products will be formally permitted under the country’s new legal framework for cannabinoids ...
US 0.3% THC limit challenge dismissed: what could it mean for hemp producers?
Written by CBD-Intel || 15th July 2022 || Regulatory briefing |
Hemp producers have lost an important challenge on the 0.3% THC threshold for hemp-derived products in the US, potentially making producers liable if they go over the threshold during production, whether or not the end product meets the...
Incoming Colombian government has big plans for the country’s cannabis industry
Written by CBD-Intel || 8th July 2022 || Regulatory briefing |
Colombian president-elect Gustavo Petro says he will prioritise development of the nation’s cannabis industry and is promising that he will improve regulation, expand the existing legal framework and clarify production regulation as well as decriminalise consumption ...
DG-Agri – the EU agency ready to put its full weight behind the growth in hemp
Written by CBD-Intel || 5th July 2022 || Business briefing |
The European Food Safety Authority (Efsa) may not be sure about CBD but the EU Directorate-general for Agriculture and Rural Development (DG-Agri) is fully behind hemp as a crop with potential ...
Why novel food rules are pushing the UK market towards cold-pressed products
Written by CBD-Intel || 4th July 2022 || Business briefing |
Companies are facing technical and marketing pros and cons as they increasingly turn to cold-press CBD extraction as a way around novel food market limitations in the UK and Ireland ...
EU novel food applications: the science behind what EFSA says it wants to know
Written by CBD-Intel || 27th June 2022 || Regulatory briefing |
The European Food Safety Authority wants more safety data before it approves CBD products as novel food. This is what it wants to know, and why, along with a summary of the science on each point ...
Recreational cannabis remains illegal in Delaware despite unusual efforts
Written by CBD-Intel || 24th June 2022 || Regulatory briefing |
A bid to legalise recreational cannabis in the US state of Delaware failed when lawmakers fell just short in a rare bid to overturn a governor's veto ...
Guyana’s leaders pin hopes on hemp bill to revive lost jobs and agriculture
Written by CBD-Intel || 21st June 2022 || Business briefing |
Government officials in Guyana believe the Industrial Hemp Bill, expected to be voted on by Parliament by the end of June, will be a big step towards the creation of a legal framework for hemp cultivation and manufacturing...
Mixed reception for Minnesota law on hemp-derived cannabinoid products
Written by CBD-Intel || 17th June 2022 || Regulatory briefing |
A new law makes Minnesota the first state in the US to apply a 21+ age restriction to all hemp-derived cannabinoid products regardless of potential for intoxication ...
Changes ahead in Rhode Island as adult recreational cannabis sales are legalised
Written by CBD-Intel || 16th June 2022 || Regulatory briefing |
Cannabis will be available for recreational use in Rhode Island from 1st December after governor Dan McKee signed the Rhode Island Cannabis Act into law, making the state the 19th in the US to legalise adult use ...
How do you tell if a user is under the influence? It’s still a testing problem
Written by CBD-Intel || 14th June 2022 || Regulatory briefing |
While cannabis use is now legal in many US states, there is as yet no reliable test to determine whether, or how far, a user may be “under the influence” ...
California cannabis cultivation tax stands to be eliminated imminently
Written by CBD-Intel || 10th June 2022 || Regulatory briefing |
Tax on the cultivation of cannabis in California could be eliminated as of July ...
Lausanne aims to become home to Switzerland’s second cannabis trial
Written by CBD-Intel || 8th June 2022 || Regulatory briefing |
Lausanne could become the second Swiss city after Basel to launch a recreational cannabis trial this year. But while Basel’s pilot will involve just 400 participants, Lausanne is aiming for triple that number ...
Peru’s health ministry publishes draft legal framework for medical cannabis
Written by CBD-Intel || 3rd June 2022 || Regulatory briefing |
The Peruvian Health Ministry has published a draft legal framework that will regulate the medicinal and therapeutic cannabis market following the 16th May resolution promising such a move ...
SAFE dominates as cannabis lobbyists in the US spend more than $12m in Q1 2022
Written by CBD-Intel || 2nd June 2022 || Regulatory briefing |
Spending on CBD- and cannabis-related lobbying in the US exceeded pre-pandemic numbers, with more than $12m spent during the first quarter of 2022 on issues such as efforts to support patient safety, legalisation and decriminalisation ...
Germany puts legal cannabis back up the agenda – but EU and UN obstacles remain
Written by CBD-Intel || 26th May 2022 || Regulatory briefing |
The German government has performed an abrupt U-turn on recreational cannabis legislation just three months after the new coalition government said such plans were not among its priorities for this year ...
Canada’s cannabis industry gathering to urge the government to move faster
Written by CBD-Intel || 25th May 2022 || Business briefing |
Canada’s cannabis industry is planning a two-day blitz of Parliament Hill in a bid to convince the government to launch its long overdue review of federal cannabis legislation ...
UK FSA’s slow-moving novel food authorisation process feeds frustration
Written by CBD-Intel || 20th May 2022 || Regulatory briefing |
It’s been two years since the deadline for CBD companies to apply for the Food Standards Agency (FSA) novel foods authorisation, yet none have been authorised and few have been validated ...
Belize cannabis and hemp legalisation bill faces opposition, late referendum
Written by CBD-Intel || 17th May 2022 || Regulatory briefing |
The fate of a recently approved cannabis and industrial hemp bill in Belize is likely to be decided by a national referendum after opposition groups submitted a petition in early May in an effort to block cannabis legalisation in the Central American...